Business Context and Reporting Period
This Form 8-K was filed by MRI Interventions, Inc. on May 9, 2013. The report discloses results of operations and financial condition for the first fiscal quarter ended March 31, 2013. The company develops the ClearPoint system, an MRI-compatible trajectory frame for neurological procedures.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained in a press release (Exhibit 99.1) which is furnished but not included in the provided text.
Material Changes and Operational Data
- Product Sales: The Company sold 70 SmartFrame kits during the three months ended March 31, 2013.
- Historical Comparison: For the six-month period ended December 31, 2012, the Company sold a total of 118 SmartFrame kits.
- Product Context: The SmartFrame is the centerpiece of the ClearPoint system's disposable components. Procedures typically utilize one or two kits.
Guidance, Outlook, and Risks
The filing does not contain explicit forward-looking guidance, management commentary on future outlook, or specific risk factors within the provided text. It serves primarily as a notification of the press release issuance and disclosure of unit sales data under Regulation FD.
Investor Verification Checklist
- Verify the full financial results (revenue, net loss, cash position) in the press release dated May 9, 2013 (Exhibit 99.1).
- Confirm the conversion rate of SmartFrame kit sales to total revenue, noting that procedures may require one or two kits.
- Assess the sales trend by comparing the 70 units sold in Q1 2013 against the 118 units sold in the prior six-month period.